Trials / Recruiting
RecruitingNCT06010199
Risk Stratification Value of Biomarkers in Patients With Myocarditis
Risk Stratification Value of Biomarkers in Patients With Myocarditis (FORWARD): a National, Multicenter, Retrospective-prospective, Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
- Sex
- All
- Age
- 3 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.
Detailed description
The aim of this study is to retrospectively and prospectively collect clinical data and biological specimens from patients with myocarditis who meet the inclusion and exclusion criteria. General molecular biology analysis, genome sequencing, transcriptome sequencing, methylation sequencing, metabolomics analysis, proteomics analysis, genome-wide chromosome conformation capture and other techniques are used to construct a prognosis prediction model for myocarditis.
Conditions
Timeline
- Start date
- 2023-08-25
- Primary completion
- 2030-07-31
- Completion
- 2030-08-31
- First posted
- 2023-08-24
- Last updated
- 2024-07-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06010199. Inclusion in this directory is not an endorsement.